Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2026-07-25), Fresenius Medical Care AG's 6-1 Month Momentum % is 8.31%.
The industry rank for Fresenius Medical Care AG's 6-1 Month Momentum % or its related term are showing as below:
FMS's 6-1 Month Momentum % is ranked better than 80.36% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: -10.415
vs FMS: 8.31
Fresenius Medical Care AG (NYSE:FMS) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Fresenius Medical Care AG 6-1 Month Momentum % Related Terms
FMS vs HCA, THC, DVA: 6-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG 6-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's 6-1 Month Momentum % falls into.
Fresenius Medical Care AG (NYSE:FMS) 6-1 Month Momentum % Calculation
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum %
=
( Price 1-month ago
/
Price 6-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG (FMS) has a 6-1 Month Momentum % of 8.31% as of Jul. 25, 2026. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Fresenius Medical Care AG and its competitors. According to the industry distribution chart, Fresenius Medical Care AG ranks #132 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 19.6%.
Is Fresenius Medical Care AG's 6-1 Month Momentum % too high?
Fresenius Medical Care AG's current 6-1 Month Momentum % is 8.31%. Based on the distribution chart, Fresenius Medical Care AG ranks #132 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's 6-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #132 out of 672 companies for 6-1 Month Momentum %. This places Fresenius Medical Care AG in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-1 Month Momentum % for a Healthcare Providers & Services company?
A good 6-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 6-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-1 Month Momentum % mean?
A high 6-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 6-1 Month Momentum measures the total return of the stock from 6-month ago to 1-month ago. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current 6-1 Month Momentum % is 8.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $23.58, compared to a current price of $24.59 — trading 4.3% above its estimated fair value. The current 6-1 Month Momentum % is 8.31%. Fresenius Medical Care AG's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-1 Month Momentum % calculated?
6-1 Month Momentum % is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current 6-1 Month Momentum % is 8.31% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMS) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued.
The current stock price of $24.59 is trading 4.3% above its estimated GF Value™ of $23.58.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMS:
6-1 Month Momentum %: 8.31%
GF Value™: $23.58 vs. price of $24.59 (4.3% above fair value)
No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
76GF Score
Get the complete analysis for FMS
6-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMS has been successfully added to your 
